February 5, 2018 05:00 PM EST

Pfizer vs J&J: Researchers are duking it out for the championship title in nonmetastatic prostate cancer

Pfizer $PFE and J&J $JNJ have come down to the wire with pivotal data on nonmetastatic prostate cancer. And there are billions of dollars in …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Pfiz­er vs J&J: Re­searchers are duk­ing it out for the cham­pi­onship ti­tle in non­metasta­t­ic prostate can­cer